Izadi Z, Gandrup J, Katz PP, et al. Patient-reported outcome measures for use in clinical trials of SLE: a review. Lupus Sci Med 2018;5:e000279. doi: 10.1136/lupus-2018-000279

The authors noticed a potential data inconsistency in the published version. The 7th statement needs to be updated in the first paragraph of the ‘Lupus Impact Tracker’ at page 10.

The corrected information is: MIDs range from 2 to 4 for clinical deteriorations and an MID of −8.2 points has been reported for clinical improvements.^{83 87}